|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Hepatitis C and Alcohol Exacerbate Liver Injury by Suppression of FOXO3显示文摘 | Batbayar Tumurbaatar Irina Tikhanovich Zhuan Li Jinyu Ren Robert Ralston Sudhakiranmayi Kuravi Roosevelt Campbell Gaurav Chaturvedi Ting-Ting Huang Jie Zhao Junfang Hao Maura O’Neil Steven A. Weinman | 2013 | The American Journal of Pathology2013，，6： | 2 |
| 2 | Nematic 2, 5-disubstituted thiophenes 显示文摘 | Neil L Campbell Warren L Duffy Gareth I Thomas | 2002 | J Mater Chem2002，12，： | 1 |
| 3 | Review of exer- cise studies in breast cancer survivors: attention to princi- ples of exercise training显示文摘 | Campbell KL Neil SE Winters-Stone KM | 2012 | British Journal of Sports Medi- cine2012，12，： | 1 |
| 4 | Smart bridges, smart tunnels: Transforming wireless sensor networks from research prototypes into robust engineering infrastructure显示文摘 | Frank Stajano Neil Hoult Ian Wassell Peter Bennett Campbell Middleton Kenichi Soga | 2010 | Ad Hoc Networks2010，，8： | 1 |
| 5 | Review of exer- cise studies in breast cancer survivors: attention to princi- ples of exercise training显示文摘 | Campbell KL Neil SE Winters-Stone KM | 2011 | Br J Sports Med2011，54，6： | 1 |
| 6 | Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase Ⅱ randomised placebo-controlled double-blind multicentre trial显示文摘Rationale Haematoma growth is common early after intracerebral haemorrhage(ICH),and is a key determinant of outcome.Tranexamic acid,a widely available antifibrinolytic agent with an excellent safety profile,may reduce haematoma growth.Methods and design Stopping intracerebral haemorrhage with tranexamic acid for hyperacute onset presentation including mobile stroke units(STOP-MSU)is a phase Ⅱ double-blind,randomised,placebo-controlled,multicentre,international investigator-led clinical trial,conducted within the estimand statistical framework.Hypothesis In patients with spontaneous ICH,treatment with tranexamic acid within 2 hours of onset will reduce haematoma expansion compared with placebo.Sample size estimates A sample size of 180 patients(90 in each arm)would be required to detect an absolute difference in the primary outcome of 20%(placebo 39%vs treatment 19%)under a two-tailed significance level of 0.05.An adaptive sample size re-estimation based on the outcomes of 144 patients will allow a possible increase to a prespecified maximum of 326 patients.Intervention Participants will receive 1 g intravenous tranexamic acid over 10 min,followed by 1 g intravenous tranexamic acid over 8 hours;or matching placebo.Primary efficacy measure The primary efficacy measure is the proportion of patients with haematoma growth by 24±6 hours,defined as either≥33%relative increase or≥6 mL absolute increase in haematoma volume between baseline and follow-up CT scan.Discussion We describe the rationale and protocol of STOP-MSU,a phase Ⅱ trial of tranexamic acid in patients with ICH within 2 hours from onset,based in participating mobile stroke units and emergency departments. | Nawaf Yassi Henry Zhao Leonid Churilov Bruce C V Campbell Teddy Wu Henry Ma Andrew Cheung Timothy Kleinig Helen Brown Philip Choi Jiann-Shing Jeng Annemarei Ranta Hao-Kuang Wang Geoffrey C Cloud Rohan Grimley Darshan Shah Neil Spratt Der-Yang Cho Karim Mahawish Lauren Sanders John Worthington Ben Clissold Atte Meretoja Vignan Yogendrakumar Mai Duy Ton Duc Phuc Dang Nguyen Thai My Phuong Huy-Thang Nguyen Chung Y Hsu Gagan Sharma Peter J Mitchell Bernard Yan Mark W Parsons Christopher Levi Geoffrey A Donnan Stephen M Davis | 2022 | Stroke & Vascular Neurology2022，7，2： | 1 |
| 7 | Establishment and operation of a Good Manufacturing Practice‐compliant allogeneic Epstein‐Barr virus ( EBV )‐specific cytotoxic cell bank for the treatment of EBV ‐associated lymphoproliferative disease显示文摘 | Mark A. Vickers Gwen M. Wilkie Nicolas Robinson Nadja Rivera Tanzina Haque Dorothy H. Crawford Jacqueline Barry Neil Fraser David M. Turner Victoria Robertson Phil Dyer Peter Flanagan Helen R. Newlands John Campbell Marc L. Turner | 2014 | Br J Haematol2014，，： | 1 |
| 8 | Tumor-Induced Osteoclast miRNA Changes as Regulators and Biomarkers of Osteolytic Bone Metastasis显示文摘 | Brian Ell Laura Mercatali Toni Ibrahim Neil Campbell Heidi Schwarzenbach Klaus Pantel Dino Amadori Yibin Kang | 2013 | Cancer Cell2013，，4： | 1 |
| 9 | Dehydrogenation of tetrahydrocarbazoles by chloranil 显示文摘 | Bessie M Barclay Neil Campbell | 1945 | Chem Soc1945，，135： | 1 |
| 10 | The prognosis of atrial septal def-ect显示文摘 | Campbell M Neil C Suzman S | 1957 | Br Heart J1957，，： | 1 |
| 11 | The S pot sign and T ranexamic acid O n P reventing ICH growth – AUS tralasia T rial ( STOP‐AUST ): Protocol of a phase II randomized, placebo‐controlled, double‐blind, multicenter trial显示文摘 | Atte Meretoja Leonid Churilov Bruce C. V. Campbell Richard I. Aviv Nawaf Yassi Christen Barras Peter Mitchell Bernard Yan Harshal Nandurkar Christopher Bladin Tissa Wijeratne Neil J. Spratt Jim Jannes Jonathan Sturm Jayantha Rupasinghe Jorge Zavala Andrew | 2014 | Int J Stroke2014，，： | 1 |
| 12 | Review of exercise studies in breast cancer surivors: attention to principles of exercise training 显示文摘 | Campbell KL Neil SE Winters-Stone KM | 2012 | British Journal of Sports Medicine2012，46，16： | 1 |
| 13 | Etiology of acute lower respiratory tract infections in Gambian children 显示文摘 | Forgie IM O'Neil KP Lloyd-Evans N Leinonen M Campbell H Whittle HC | 1991 | Pediatr Infect Dis J1991，10，1： | 1 |
| 14 | Maternal outcome after conservative management of placenta percreta at caesarean section: A report of three cases and a review of the literature显示文摘 | Selvan Pather Sasha Strockyj Antony Richards Neil Campbell Brad Vries Robert Ogle | 2014 | Aust N Z J Obstet Gynaecol2014，，1： | 1 |
| 15 | Active Repression of Antiapoptotic Gene Expression by RelA(p65) NF-κB显示文摘 | Kirsteen J Campbell Sonia Rocha Neil D Perkins | 2004 | Molecular Cell2004，，： | 1 |
| 16 | Laparoscopic Repair of Giant Paraesophageal Hernia: 100 Consecutive Cases显示文摘 | James D. Luketich Siva Raja Hiran C. Fernando William Campbell Neil A. Christie Percival O. Buenaventura Robert J. Keenan Philip R. Schauer | 2000 | Annals of Surgery2000，，4： | 1 |
| 17 | The preparation of the hologenophenylacetic acids 显示文摘 | Mckail John E | 1948 | JCS1948，，： | 1 |
| 18 | Searching for a route to synthesize in situ epitaxial Pr_(2)Ir_(2)O_(7) thin films with thermodynamic methods显示文摘In situ growth of pyrochlore iridate thin films has been a long-standing challenge due to the low reactivity of Ir at low temperatures and the vaporization of volatile gas species such as IrO_(3)(g)and IrO_(2)(g)at high temperatures and high PO_(2).To address this challenge,we combine thermodynamic analysis of the Pr-Ir-O_(2)system with experimental results from the conventional physical vapor deposition(PVD)technique of co-sputtering.Our results indicate that only high growth temperatures yield films with crystallinity sufficient for utilizing and tailoring the desired topological electronic properties and the in situ synthesis of Pr_(2)Ir_(2)O_(7)thin films is fettered by the inability to grow with PO_(2)on the order of 10 Torr at high temperatures,a limitation inherent to the PVD process.Thus,we suggest techniques capable of supplying high partial pressure of key species during deposition,in particular chemical vapor deposition(CVD),as a route to synthesis of Pr_(2)Ir_(2)O_(7). | Lu Guo Shun-Li Shang Neil Campbell Paul G.Evans Mark Rzchowski Zi-Kui Liu Chang-Beom Eom | 2021 | npj Computational Materials2021，，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员